LBRX (LBRX) reported EBIT of -$19.05M in Q1 2026.

How has LBRX's EBIT changed year-over-year?

LBRX's EBIT decreased by 259.1% year-over-year, from -$5.31M to -$19.05M.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

LBRX LBRX EBIT

EBIT at other companies

MapLight Therapeutics, Inc. MPLT

-$64.5M-174%

Alto NeuroscienceANRO

-$27.14M-73.1%

Zevra Therapeutics, Inc.ZVRA

$52.15M+1,073%

Opko HealthOPK

-$51.02M+24.0%

Bristol-Myers SquibbBMY

——

AlkermesALKS

——

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+163%

Enterprise value$556.86M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Calculated from LBRX’s reported figures.

−$19.1Mincome before tax=-$19.05M

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's EBIT?: LBRX (LBRX) reported EBIT of -$19.05M in Q1 2026.
How has LBRX's EBIT changed year-over-year?: LBRX's EBIT decreased by 259.1% year-over-year, from -$5.31M to -$19.05M.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.